Biotin Anti-eIF4E (phospho S209) antibody [EP2151Y] (ab201471)
Key features and details
- Produced recombinantly (animal-free) for high batch-to-batch consistency and long term security of supply
- Biotin Rabbit monoclonal [EP2151Y] to eIF4E (phospho S209)
- Suitable for: IHC-P
- Reacts with: Human
- Conjugation: Biotin
Overview
-
Product name
Biotin Anti-eIF4E (phospho S209) antibody [EP2151Y]
See all eIF4E primary antibodies -
Description
Biotin Rabbit monoclonal [EP2151Y] to eIF4E (phospho S209) -
Host species
Rabbit -
Conjugation
Biotin -
Tested Applications & Species
See all applications and species dataApplication Species IHC-P Human -
Immunogen
This information is proprietary to Abcam and/or its suppliers.
-
Positive control
- IHC-P: human breast cancer tissue (Adenocarcinoma).
-
General notes
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
Properties
-
Form
Liquid -
Storage instructions
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C. Stable for 12 months at -20°C. Store In the Dark. -
Storage buffer
pH: 7.40
Preservative: 0.02% Sodium azide
Constituents: PBS, 30% Glycerol (glycerin, glycerine), 1% BSA -
Concentration information loading...
-
Purity
Protein A purified -
Clonality
Monoclonal -
Clone number
EP2151Y -
Isotype
IgG -
Research areas
Images
-
IHC image of eIF4E (phospho S209) staining in a section of formalin-fixed paraffin-embedded human breast cancer (adenocarcinoma)*, performed on a Leica Bond system using the standard protocol B. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20 mins. The section was then incubated with ab201471 at 1/50 dilution, for 15 mins at room temperature and detected using an HRP conjugated ABC system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.
The inset negative control image is taken from an identical assay without primary antibody.
For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.
*Tissue obtained from the Human Research Tissue Bank, supported by the NIHR Cambridge Biomedical Research Centre.
-